STAA · Staar Surgical Co
$26.18
+0.85 (+3.36%)
At close · Aug 14
Market Cap
$1.31B
Shares
50.14M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Stephen Farrell | CEO | $7,522,385 |
| Stephen C. Farrell | Chief Executive Officer | $7,522,385 |
| Warren Foust | President and Chief Operating Officer | $4,440,664 |
| Nathaniel B. Sisitsky | Chief Legal Officer and | $2,765,962 |
| Magda Michna | Chief Development Officer | $2,695,752 |
| Deborah Andrews | Chief Financial Officer | $2,582,411 |
| Thomas G. Frinzi | Former President and Chief Executive Officer | $1,255,915 |
| Patrick Williams | Former Chief Financial Officer | $926,941 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas G. Frinzi | President and Chief Executive Officer | $7,821,216 |
| Warren Foust | Chief Operating Officer | $2,903,669 |
| Patrick Williams | Chief Financial Officer | $2,898,889 |
| Magda Michna | — | $2,313,683 |
| Nathaniel B. Sisitsky | General Counsel and Corporate Secretary | $2,131,935 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Thomas G. Frinzi | President and Chief Executive Officer | $10,220,581 |
| Warren Foust | Chief Operating Officer | $3,250,292 |
| Patrick Williams | Chief Financial Officer | $2,816,869 |
| Scott Barnes | Chief Medical Officer | $2,484,316 |
| Keith Holliday | Chief Technology Officer | $2,410,817 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Caren Mason | Former President and Chief Executive Officer | $6,501,953 |
| Patrick Williams | Chief Financial Officer | $3,030,055 |
| Scott Barnes | Chief Medical Officer | $2,621,451 |
| Keith Holliday | Chief Technology Officer | $2,560,605 |
| James Francese | Senior Vice President, Commercial Commercial Operations Asia Pacific and North America | $2,540,925 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Caren Mason | Former President and Chief Executive Officer | $5,468,270 |
| Hans Blickensdoerfer | Senior Vice President, Commercial Operations Direct Markets Europe, China | $3,550,231 |
| Scott Barnes | Chief Medical Officer | $1,405,188 |
| Patrick Williams | Chief Financial Officer | $1,389,052 |
| Keith Holliday | Chief Technology Officer | $1,269,606 |
| James Francese | Senior Vice President, Commercial Commercial Operations Asia Pacific and North America | $1,116,317 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Hans Blickensdoerfer | Senior Vice President, Commercial Operations Direct Markets Europe, China | $4,334,678 |
| Caren Mason | Former President and Chief Executive Officer | $2,975,812 |
| Patrick Williams | Chief Financial Officer | $1,847,445 |
| Scott Barnes | Chief Medical Officer | $1,142,512 |
| Keith Holliday | Chief Technology Officer | $978,378 |
| James Francese | Senior Vice President, Commercial Commercial Operations Asia Pacific and North America | $858,798 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Caren Mason | President and Chief Executive Officer | $3,616,037 |
| Scott Barnes | Vice President, Chief Medical Officer | $1,246,350 |
| Hans Blickensdoerfer | Senior Vice President, Commercial Operations Direct Markets Europe, China | $1,076,798 |
| Keith Holliday | Vice President, Chief Technology Officer | $1,072,826 |
| Deborah Andrews | Vice President, Chief Financial Officer | $854,212 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Caren Mason | President and Chief Executive Officer Patrick F. Williams^(^^4)^ | $2,627,201 |
| Hans Blickensdoerfer | Senior Vice President, Commercial Operations Direct Markets Europe, China | $1,102,581 |
| Keith Holliday | Vice President, Chief Technology Officer Deborah Andrews^(^^7)^ | $1,092,223 |
| Scott Barnes | Vice President, Chief Medical Officer Hans Blickensdoerfer^(^^5)^ | $948,643 |
| Deborah Andrews | Vice President, Chief Financial Officer | $823,480 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Caren Mason | President and Chief Executive Officer | $1,866,011 |
| Deborah Andrews | Vice President, Chief Financial Officer | $865,056 |
| Keith Holliday | Vice President, Chief Technology Officer | $853,308 |
| Hans Blickensdoerfer | Senior Vice President, Commercial Operations Direct Markets Europe, China | $699,424 |
| Scott Barnes | Vice President, Chief Medical Officer | $608,325 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Warren Foust | new member of the Board | Appointed | 2026-08-06 |
| Warren Foust | President and Chief Executive Officer ("CEO") | Appointed | 2026-08-06 |
| Nathaniel Sisitsky | Chief Legal Officer and Corporate Secretary | Terminated | 2026-02-05 |
| Deborah Andrews | Interim Co-Chief Executive Officer | Appointed | 2026-02-02 |
| Warren Foust | Interim Co-Chief Executive Officer | Appointed | 2026-02-02 |
| Louis E. Silverman | Compensation Committee Chair | Appointed | 2026-01-16 |
| Lilian Y. Zhou | Audit Committee Chair | Appointed | 2026-01-16 |
| Neal C. Bradsher | Board Chair | Appointed | 2026-01-16 |
| Christopher Min Fang Wang | Board | Appointed | 2026-01-15 |
| Richard T. LeBuhn | Board | Appointed | 2026-01-15 |
| Neal C. Bradsher | Board | Appointed | 2026-01-15 |
| Stephen C. Farrell | Chief Executive Officer | Terminated | 2026-01-15 |
| Elizabeth Yeu, MD | Board | Resigned | 2026-01-15 |
| Stephen C. Farrell | member of the Board | Resigned | 2026-01-15 |
| Deborah Andrews | Chief Financial Officer | Appointed | 2025-06-25 |
| Louis E. Silverman | director | Appointed | 2025-04-24 |
| Keith Holliday | Chief Technology Officer | Retired | 2025-03-18 |
| Magda Michna | Chief Development Officer | Appointed | 2025-03-18 |
| Deborah Andrews | Interim Chief Financial Officer | Appointed | 2025-03-18 |
| Deborah Andrews | principal accounting officer | Appointed | 2025-03-18 |
| Warren Foust | President and Chief Operating Officer | Appointed | 2025-03-18 |
| Elizabeth Yeu, M.D. | Board Chair | Appointed | 2025-02-26 |
| Stephen C. Farrell | President and Chief Executive Officer | Appointed | 2025-02-26 |
| Aimee S. Weisner | director | Appointed | 2024-06-21 |
| Elizabeth Yeu, MD | director | Appointed | 2024-06-21 |
Key facts
CIK
718937
CUSIP
852312305
13F (30d)
198 filings
187 filers
Visit website
Investor relations